Average cost of multi drug-resistant tuberculosis treatment in Dominican Republic
Dominican Republic: Average cost of multi drug-resistant tuberculosis treatment was 1,650 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
1,650 constant 2022 US$
Change on year
down 5.7%
World rank
28th
of 92 countries
All-time high
2,400 constant 2022 US$
in 2019
All-time low
1,421 constant 2022 US$
in 2018
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Dominican Republic, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of multi drug-resistant tuberculosis treatment in Dominican Republic stood at 1,650 constant 2022 US$.
That represents a change of down 5.7% on the previous year and down 18.8% over ten years.
Dominican Republic ranks 28th of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Dominican Republic, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,031 constant 2022 US$ | — |
| 2018 | 1,421 constant 2022 US$ | -30.0% |
| 2019 | 2,400 constant 2022 US$ | +68.9% |
| 2020 | 2,400 constant 2022 US$ | +0.0% |
| 2021 | 1,749 constant 2022 US$ | -27.1% |
| 2022 | 1,749 constant 2022 US$ | +0.0% |
| 2023 | 1,749 constant 2022 US$ | +0.0% |
| 2024 | 1,650 constant 2022 US$ | -5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,951 constant 2022 US$ | 1,421 constant 2022 US$ | 2,400 constant 2022 US$ | 3 |
| 2020s | 1,859 constant 2022 US$ | 1,650 constant 2022 US$ | 2,400 constant 2022 US$ | 5 |
Countries ranked near Dominican Republic
More health data for Dominican Republic
- Un projection of annual infant deaths, annual growth rate -2.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5233 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,287 deaths per 1,000 people (2090)
- Number of infants who die before age 1 598 deaths (2100)
- Population ages 30-34, female, annual growth rate 0.564 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0386 units per person (2025)
- Population ages 30-34, male, annual growth rate 0.733 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0392 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Dominican Republic?
- Average cost of multi drug-resistant tuberculosis treatment in Dominican Republic was 1,650 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Dominican Republic?
- The highest recorded value was 2,400 constant 2022 US$ in 2019.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Dominican Republic?
- The lowest recorded value was 1,421 constant 2022 US$ in 2018.
- How does Dominican Republic rank for average cost of multi drug-resistant tuberculosis treatment?
- Dominican Republic ranks 28th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Dominican Republic?
- Over the last ten years it is down 18.8%. The long-run trend across the full record is falling.
- Where does this Dominican Republic data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.